SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950135-96-000094
Filing Date
1996-01-10
Accepted
1996-01-10 00:00:00
Documents
7
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 GENOME THERAPEUTICS CORP. S-3 273494
2 UNDERWRITING AGREEMENT EX-1 83411
3 SPECIMEN STOCK CERTIFICATE EX-4.1 3280
4 WARRANT AGREEMENT EX-4.2 62869
5 OPINION OF ROPES & GRAY EX-5 2396
6 CONSENT OF ARTHUR ANDERSEN LLP EX-23.2 417
7 CONSENT OF LAHIVE AND COCKFIELD EX-23.3 792
  Complete submission text file 0000950135-96-000094.txt   428765
Mailing Address 100 BEAVER STREET WALTHAM MA 02154
Business Address 1OO BEAVER ST WALTHAM MA 02154 6178935007
GENOME THERAPEUTICS CORP (Filer) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
Type: S-3 | Act: 33 | File No.: 333-00127 | Film No.: 96502190
SIC: 2835 In Vitro & In Vivo Diagnostic Substances